ADELINA ORONOVA

Dr. ADELINA ORONOVA

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2023 in Chemical & Biomedical Imaging
Verified
Journal Article
Open access
MHMonica Soma Hensley
Monica Soma Hensley
AOADELINA ORONOVA
ADELINA ORONOVA
NGNazar Gora
Nazar Gora
MGMicaela Rayne Geborkoff
Micaela Rayne Geborkoff
NONathan Randal Ostlund
Nathan Randal Ostlund
MTMarina Tanasova
Marina Tanasova
The direct relationship between facilitative glucose transporters (GLUTs) and metabolic diseases opens new avenues for sensing metabolic deregulations and drives the development of molecular probes for GLUT-targeted detection of metabolic diseases. Radiotracer-based molecular imaging probes have been effectively utilized in reporting alterations in sugar uptake as an indication of metabolic deregulations, cancer development, or inflammation. Progress in developing fluorophore-based tools facilitated GLUT-specific analyses using more accessible fluorescence-based instrumentation. However, restrictions on the emission range of fluorophores and the requirement for substantial post-treatments to reduce background fluorescence have brought to light the critical directions for improvement of the technology for broader use in screening applications. Here we present turn-on GLUT activity reporters activated upon cells' internalization. We demonstrate a specific delivery of a sizable rhodamine B fluorophore through GLUT5 and showcase a stringent requirement in conjugate structure for maintaining a GLUT-specific uptake. With the turn-on GLUT probes, we demonstrate the feasibility of high-throughput fluorescence microscopy and flow cytometry-based GLUT activity screening in live cells and the probes' applicability for assessing sugar uptake alterations in vivo.

2 May 2024 in ACS Chemical Health & Safety
Verified
Journal Article
Closed access
CDCaroline Donaghy
Caroline Donaghy
AOADELINA ORONOVA
ADELINA ORONOVA
ASAishanee Sur
Aishanee Sur
DHDaniel D. Hu
Daniel D. Hu
EREmily E. A. Robinson
Emily E. A. Robinson
MHMonica Soma Hensley
Monica Soma Hensley

Verified
Journal Article
Open access
PDF file
AOADELINA ORONOVA
ADELINA ORONOVA
MTMarina Tanasova
Marina Tanasova
The targeting of facilitative sugar transporters (GLUTs) has been utilized in the development of tools for diagnostics and therapy. The interest in this area is promoted by the phenomenon of alterations in cellular metabolic processes that are linked to multitudes of metabolic disorders and diseases. However, nonspecific targeting (e.g., glucose-transporting GLUTs) leads to a lack of disease detection efficiency. Among GLUTs, GLUT5 stands out as a prominent target for developing specific molecular tools due to its association with metabolic diseases, including cancer. This work reports a non-radiolabeled fluoride (19F) coumarin-based glycoconjugate of 2,5-anhydro-D-mannitol as a potential PET imaging probe that targets the GLUT5 transporter. Inherent fluorescent properties of the coumarin fluorophore allowed us to establish the probe’s uptake efficiency and GLUT5-specificity in a GLUT5-positive breast cell line using fluorescence detection techniques. The click chemistry approach employed in the design of the probe enables late-stage functionalization, an essential requirement for obtaining the radiolabeled analog of the probe for future in vivo cancer imaging applications. The high affinity of the probe to GLUT5 allowed for the effective uptake in nutrition-rich media.

26 December 2025 in Chemistry – A European Journal
Verified
Journal Article
Closed access
AOADELINA ORONOVA
ADELINA ORONOVA
GBGiovanna Bobnock
Giovanna Bobnock
VBVagarshak V. Begoyan
Vagarshak V. Begoyan
MTMarina Tanasova
Marina Tanasova